TVGNWTevogen Bio Holdings Inc. Warrant
0.0495USD-4.62%Mkt Cap: P/E:

Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, wh…

Key Statistics

Company
Market Cap
Enterprise Value
Revenue (TTM)
Gross Profit
Net Income (TTM)-26.28M $
Revenue/Share
Last Price0.0495 USD
Fiscal Year End
MR Quarter
Employees18
CountryUS
SectorFinancial Services
Industry
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA
EV/Revenue
P/S
P/B-0.01
EPS (TTM)
EPS (Forward)
52W Range
0.033968% of range0.0570
52W High0.0570 USD
52W Low0.0339 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE319.08%
ROA-599.49%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-12.33M $
CapEx (TTM)64.44K $
FCF Margin
FCF Yield
Net Debt8.78M $
Net Debt/EBITDA-0.42
Balance Sheet
Debt/Equity-0.91
Current Ratio0.29
Quick Ratio0.12
Book Value/Sh-4.4720 USD
Cash/Share0.1650 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.
Float1.07M
Insiders
Institutions
Technical
SMA 50
SMA 200
Beta0.20
S&P 52W Chg18.16%
Avg Vol (30d)49.20K
Avg Vol (10d)
Technical Indicators
RSI (14)69.0
MACD0.0050
MACD Signal0.0039
MACD Hist.+0.0011
BB Upper0.0617 USD
BB Middle0.0418 USD
BB Lower0.0218 USD
BB Width95.60%
ATR (14)0.0044 USD
Vol Ratio (20d)0.18x